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Objective: To describe parents’ knowledge, attitudes, and decision-making with regard to obtaining the HPV vaccine for their
daughters.Methods:White,Black,andHispanicparentsofdaughterswhowereageeligible toreceivetheHPVvaccine (9–17years)
wererecruitedfromcommunitysettingstoparticipateinfocusgroups.ParentswereaskedaboutknowledgeandawarenessofHPV,
decision-making about HPV vaccine, as well as preferred and actual sources of HPV information. Results: Seven focus groups
(n = 64 participants) were conducted. Groups were segmented by gender (women = 72%) and race/ethnicity (Black = 59%;
White = 23%; Hispanic = 19%). Prevalent themes included: insuﬃcient information to make informed decisions; varied
preferences for involvement in decision-making; concerns about vaccine safety; mistrust of medical providers and pharmaceutical
companies; and mismatch between actual and preferred sources of information. Discussion: Improving communication between
providers and caregivers and helping parents to access information necessary for informed decision-making, while alleviating
concerns about vaccine safety, may help to improve vaccine acceptance.
1.Introduction
It is well established that recurrent infection with HPV (hu-
man papillomavirus) is responsible for most cervical cancers
[1]. With the availability of prophylactic HPV vaccines,
there is potential to virtually eliminate disparities in cervical
cancer,providedthataccessisassuredanduptakeisequitable
across population groups.
Currently, routine vaccination is recommended for girls
aged 11-12, with “catch up” vaccination recommended
between ages 13–26 [2]. Vaccine eﬃcacy is highest when
administered prior to sexual d´ ebut [3]. Given the rec-
ommended age for administration, parents have decision-
making authority for their minor children. Understanding
factors that inﬂuence parental decision-making about vacci-
nating their children may improve HPV vaccination uptake.
A number of reviews have summarized sociodemo-
graphic, cognitive, and attitudinal factors associated with
parental acceptance of HPV vaccination [4, 5]. To date, the
majority of studies have been conducted among relatively
homogeneous samples in clinical settings. We sought to
gain a contextualized understanding of vaccine decisions
among a racially/ethnically diverse group of parents. We
used focus group methodology to illuminate a wide range
of perspectives and yield new insights to inform the design
of eﬀective interventions and communication strategies [6].
2. Methods
We developed a focus group guide consisting of open-ended
questions (Table 1). Discussion questions were developed
from our prior work [7, 8] and existing literature on factors
associated with parental acceptance of the HPV vaccine.
During February and May of 2008 we conducted seven
focus groups, each with 6–10 parents, Eligible participants2 Journal of Oncology
Table 1: Focus group questions.
Construct Sample question
Sources of health information Where do you get information about your daughter’s health?
What is the most credible/believable source of information?
Decision-making about daughter’s health
Who makes decisions about your daughter’s health?
Under what circumstances would you involve your daughter in making a decision about her
health care?
Awareness and knowledge of HPV
What do you know about HPV or human papillomavirus?
How is it spread?
Who is vulnerable to it?
What health problems can it cause?
Awareness and knowledge of HPV vaccine
Have you heard about a vaccine for HPV?
What have you heard?
Who is this vaccine for?
What does it do?
Social and subjective norms about HPV
vaccination
Are people in your community getting their daughters vaccinated? Why or why not? What
would your (spouse/partner; family members; friends) think about your getting your
daughter vaccinated for HPV?
Barriers to vaccination Is it diﬃcult to get this vaccine?
Why or why not?
Desired information What would you need to know before making a decision about vaccinating your
daughter(s)?
Preferred sources and settings for HPV
information delivery
What would be the best way to deliver information about the HPV vaccine to parents?
Where do you prefer to receive information?
From what source?
were primary caregivers (female or male, hereafter called
“parents”) of at least one girl between 9 and 17 years of age.
Parents were English or Spanish speaking and self-identiﬁed
as White, Black, or Hispanic. We recruited participants
throughhealthandsocialserviceagenciesintheBostonmet-
ropolitan area through ﬂiers and word of mouth.
Groups were segmented on gender and race/ethnicity, to
allow for examination of potential diﬀerences across these
characteristics. Trained focus group moderators, matched to
gender and language of participants, facilitated discussions
according to a standardized protocol. Discussions were au-
dio taped, professionally transcribed, and translated. Each
discussion lasted 60–90 minutes. Participants received a $50
gift card. The Harvard School of Public Health Institutional
Review Board approved this study.
3.Analysis
We analyzed focus group transcripts based on procedures
outlined by Corbin and Strauss [9]. Several authors (JDA,
MDJ, LT) independently examined transcripts to identify
themes and create initial coding categories. We subsequently
reviewed categories and supporting quotes to develop a
reﬁned coding scheme. Through an iterative process, open
codes were collapsed into higher-order categories that
reﬂected emergent themes. Where divergent interpretations
of themes occurred, we reevaluated and discussed the origi-
nal transcripts until consensus was achieved. Data collection
was stopped at the point of saturation [10].
4. Results
4.1. Characteristics of Participants. Seven focus groups were
conducted with a total of 64 participants. The majority of
participants were nonwhite (Black = 59%; Hispanic = 19%;
White = 23%) and female (72%). Participants’ mean age was
46. Nearly all (98%) reported having health insurance (data
not shown).
5. Themes
Themes are presented in the order of discussion, which was
driven by the focus group guide. We note where themes were
salient or emerged exclusively in particular groups. Refer to
Table 2 for sample quotes supporting themes.
5.1. Insuﬃcient Information to Make Informed Decisions. The
majority of parents felt that they did not have adequate
information about HPV or the vaccine to make an informed
decision about vaccinating their children. A number of
participants confused HPV with HIV or Hepatitis. Many
of the men had never heard of HPV prior to the focus
group. In each of the discussions among women, at least
one person shared that they had allowed one or more of
their daughters get the vaccine, although they felt that they
had been inadequately informed or were unprepared for the
decision. In some cases, participants reported that they were
notgiventheopportunitytobeinvolvedindecision-making.Journal of Oncology 3




“I didn’t give it [HPV vaccine] to my daughter when the doctor asked because I wasn’t aware of the
consequences. I need more research on it before I put her through something like that.” (Black female)
“Men need to get information so that we can get more educated about HPV.” (Black male)
“She got [the vaccine], but I am not well-informed. I don’t know what eﬀects it could have on her. I was not
given the information ...” (Latino female)
“My daughter just got the shot. And I don’t even know what she got ...You know I don’t even know how to
say it. Papee-glorenoma virus” (White female)
“They don’t explain much to you. They give you a paper with the risks ...” (White female)
Involvement in decision
making
“I leave it up to my daughter and her mother to decide what to do about the HPV vaccine.” (Black male)
“I make that decision. Her body is mine until she’s 18 years old.” (Black female)
“I would ask some of the women in my family for their opinion ...my aunt. I would get her opinion and my
sister’s, too.” (Latino male)
“When I went to the doctor with my daughter, I was asked to leave the oﬃce as the doctor wanted to have a
private conversation about the HPV vaccine with her. When they were ﬁnished, I came back in. I asked the
doctor, “What’s going on?” The doctor didn’t tell me anything ...I am kind of confused ...because the
doctor didn’t say anything to me about it [vaccine].” (Latino female)
”I think it’s better between the daughter and the health care provider” (White male)
“I would let the decision be up to her, but she should be informed. The more informed she is, the better oﬀ
she’ll be making the decision, and she won’t feel forced by you, or anybody else ...” (White female)
Concerns about vaccine
safety
“My ﬁrst thought was, I am sendin’ my ten-year old to this clinic to put dead HPV cells in her. What if the
HPV that they are shooting in her body ...what if it comes to life?” (Black female)
“[They] tried to give me an HPV shot, along with others, while in prison. It was a trial.” (Black male)
Mistrust-pharmaceutical
companies
“...all those pharmaceuticals care about, let’s be honest, is money.” (Black female)
“Are the companies who are putting the HPV vaccine out here ...are they doing it just for a proﬁt? Or do
they actually really care about treatment and prevention?” (Black female)
“If it’s been around and studied for this long, then why is it just now starting to hit the market, and why is it
just now starting to get pushed?” (Black male)
Mistrust-medical providers “I was pregnant thirteen times but ...it’s [HPV] never, ever once [taps on table for emphasis] come up with
my doctor! Never once have they even mentioned [HPV]!” (Black female)
Sources of information
“I don’t think the TV commercials explain enough, all they say is “one less, one less, one less.” I would like to
know how long the vaccine is good for and its eﬀectiveness.” (Black female)
“I know about HPV and the vaccine because they advertise the HPV vaccine a thousand times on Univision
and Telemundo.” (Latino female)




“You can’t use big words, you need to make it understandable so that people can understand [the vaccine
information] and make decisions.” (Black female)
“For me, the more information channels there is, the better: written, video, discussions ...Sometimes you
don’t understand something one way and you understand it in a diﬀerent format.” (Latino male)
“Sometimes, because you don’t know the language, you don’t even ask.” (Latino female)
In other instances, parents reported that they were given a
fact sheet, but not the opportunity to ask questions.
5.2. Responsibility for Decision-Making. Parents expressed a
wide range of perspectives in terms of the extent of in-
volvement inthe decision-making process they wanted for
themselves and their daughters. In general, fathers indicated
that they would defer decision-making to female fam-
ily members (e.g., grandmothers, godmothers) or trusted
friends, particularly among the African American and His-
panic groups. The desire for a collaborative decision-making
process between the provider, parent, and daughter was
commonly expressed by Hispanic mothers. For example,
several Hispanic mothers related stories about concern when
health care providers discussed the vaccine with their daugh-
ter privately and not involving the parent in discussions.
This was a cause of concern for these parents, who felt
that providers should have involved both the parent and
daughter in the decision. The opinion that the primary
female caregiver should make decisions (without necessarily
involving the daughter) appeared to be most common
among African American women. A view more commonly
expressed among White women was that the decision could
or should be left to the daughter, depending on age and
maturity level, and as long as she was adequately informed
about the vaccine.
5.3. Concerns about Vaccine Safety. All of the groups raised
concerns about vaccine safety. Many shared the opinion that
there may be vaccine side eﬀects yet unknown. Concerns
about unknown, long-term side eﬀects were most frequently4 Journal of Oncology
discussedamongAfricanAmericangroups.Themostpromi-
nent vaccine safety concerns among Hispanic mothers were
birth defects and future reproductive health.
5.4.MistrustofMedicalProvidersandPharmaceuticalCompa-
nies. Mistrust of medical providers was expressed by at least
one individual in each of the groups. Females, in particular,
expressed skepticism and surprise that they had not previ-
ously heard about HPV until the vaccine became available.
Some expressed anger at providers for not having previously
discussed this “killer virus.” Participants also discussed their
mistrust of pharmaceutical companies, with some perceiving
distributionofvaccineassolelyproﬁtdriven.Pharmaceutical
company mistrust appeared most prevalent among African
American groups, where participants drew parallels between
being injected with a virus and the Tuskegee experiment.
5.5. Mismatch between Actual Versus Preferred Sources of
Information. The majority of parents reported that they
preferred to receive vaccine information directly from their
daughter’s health care provider. At the same time, there was
much discussion about feeling rushed at medical appoint-
ments, not having suﬃcient opportunities to ask questions,
and as previously mentioned, a sense that health care
providers had been withholding information about HPV.
While providers were the preferred sources of information,
the vast majority of participants stated that their primary
source of information about HPV and the vaccine had
been television and radio advertisements. Participants in all
groups reported seeing advertisements for the vaccine and
speciﬁcally identiﬁed the “One Less” campaign. Many ex-
pressed concern that advertisements provided insuﬃcient,
misleading, or inaccurate information.
6. Discussion
In this qualitative study of ethnically diverse parents, knowl-
edge and awareness of HPV and the vaccine was low.
Parents almost universally reported feeling that they did not
have suﬃcient information to make an informed decision
about vaccinating their daughter(s). Concerns about vaccine
safety and potential side eﬀects were also prevalent. Often,
these concerns were discussed in the context of mistrusting
pharmaceutical companies and a concern that the vaccine
is being promoted solely for proﬁt. In these respects, our
ﬁndings are consistent with recent studies of parental knowl-
edge and attitudes toward the HPV vaccine [5, 11].
Our ﬁndings shed new light on parental desire for, and
experienceswithparticipationindecision-making.Although
this study was not speciﬁcally designed to test diﬀerences
in opinion across gender or racial/ethnic groups, we noted
variations in themes between groups.
Hispanic mothers more often reported minimal involve-
ment in decision-making despite a desire to take an active
role. Most Hispanic and African American men preferred
to defer decisions to female caretakers. Whereas Hispanic
mothers reported more concern over birth defects and
reproductive health. Parents in all groups reported learning
about HPV from media sources, yet almost all reported a
preference for receiving information from their daughter’s
health care provider.
Prior to discussion of potential implications, limitations
of this study must be noted. This was a sample of conve-
nience, which limits the generalizability of our results. Our
goal, however, was not to obtain a representative sample, but
rather to hear from parents from a variety of backgrounds
and who had diverse perspectives and experiences. It is
possible that study volunteers were more interested in HPV
and more knowledgeable about the topic compared to
the general parent population. If, indeed, participants are
assumed to be more knowledgeable than the general popu-
lation, these ﬁndings further emphasize the need for HPV
vaccine interventions, as levels of knowledge and aware-
ness werelow.Lastly,wewerenot abletoexplore inter-ethnic
diﬀerences across racial groups (e.g., by country of origin
or region). We recognize the heterogeneity within each of
the groups but were limited in our analysis by sample size.
Nevertheless, our data are useful in generating hypotheses
that can be tested in future research and for informing health
communication intervention development [6].
There are several important implications of this research.
Parents need additional information about the vaccine, its
beneﬁts, and limitations. Parental reports of inadequate in-
formation or involvement in decision-making is cause for
concern for many reasons. First, participation of parents in
vaccine decisions could increase providers’ abilities to assess
ri s k so fs i d ee ﬀects.Forexample, providersneed tobe alerted
to a child’s allergies or any major illnesses, which could aﬀect
vaccine response [2]. Second, parents need to be informed of
the potentially serious (but rare) allergic reactions that can
occur,aswellasthelimitationsofthevaccine(i.e.,itdoesnot
protect against other sexually transmitted infections). Third,
increased parental knowledge about the vaccine could result
in improved rates of vaccine series completion. Currently,
most who initiate the vaccine’s series fail to receive the
required three-dose regimen [12].
Parents reported a strong preference to receive HPV-
related information directly from their daughters’ health
care provider. As such, interventions aimed at improving
provider communications with parents about HPV are
needed. Provider endorsement has been found to be an
important driver of HPV vaccination in previous studies
[5]. Providers need information and skills to eﬀectively
disseminate accurate information, help manage parental
uncertainty, respond to emotional concerns, and facili-
tate informed decision-making among parents. However,
given the mistrust expressed among some groups toward
providers, interventions will also need to foster strong
provider-patient relationships. While time constraints are a
potential barrier to developing relationships with parents,
there are ways to address this. For example, provider vaccine
recommendations can be followed by reminder mailings
and parent education on how to best prepare for a clinical
encounter.
Our ﬁnding that female caregivers often hold primary
responsibility for health decisions, particularly in relation
to the sexual health of their daughters, highlights theJournal of Oncology 5
importance of targeting HPV health communications. For
example, the importance of vaccinating young girls could
be discussed with mothers when they themselves present
for cervical cancer screening. In addition, the ﬁnding that
many parents rely on female family members and friends
for input on health-related decisions suggests that targeting
key members within an individual’s social network could be
potentially eﬀective for the dissemination of HPV vaccine
information and adherence to provider recommendations.
Finally, to address parental mistrust of pharmaceutical
companies, it will be important to deliver interventions that
are not associated with or ﬁnancially tied to the pharmaceu-
tical industry. This may help to improve program credibility
and mitigate mistrust. Given some of the public’s mistrust of
vaccines in general, providing information through trusted
and credible sources will be critical.
In conclusion, given that there is variation among eth-
nically diverse parents in the degree of desired involvement
in decision-making, it would be prudent for providers
to inquire about and respect preferences for involvement.
Understanding the diverse models of parental decision-
making about HPV vaccination would enable the develop-
ment and evaluation of much needed targeted health com-
munication interventions to promote vaccine uptake and
completion.
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